Physicians' Academy for Cardiovascular Education

Cardiovascular effects of glucose lowering: Safety vs Efficacy

Dec. 12, 2014 - AHA, Chicago VBWG - Dr Silvio E Inzucchi


Dr. Silvio E. Inzucchi, Yale School of Medicine, New haven, CT, USA, provides his perspective om current diabetes therapies and ongoing trials with DPP4 and SGLT2 inhibitors on cardiovascular safety and/or benefits